Intracellular Na in animal models of hypertrophy and heart failure: Contractile function and arrhythmogenesis

Cardiovascular Research

Volumn 57, Issue 4, 2003, Pages 887-896

  Pogwizd, Steven M ^a   Sipido, Karin R ^b   Verdonck, Fons ^c   Bers, Donald M ^d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Arrhythmia (mechanisms); Contractile function; Heart failure; Hypertrophy; Na H exchanger; Na K pump

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BICARBONATE; CALCIUM ION; MAGNESIUM ION; SODIUM CHANNEL; SODIUM ION;

ARRHYTHMOGENESIS; EXPERIMENTAL MODEL; HEART CONTRACTION; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; REVIEW; SODIUM CALCIUM EXCHANGE; SODIUM CELL LEVEL; SODIUM TRANSPORT;

ANIMALS; ARRHYTHMIA; CALCIUM; CARDIOMEGALY; DISEASE MODELS, ANIMAL; HEART FAILURE, CONGESTIVE; MYOCARDIAL CONTRACTION; SODIUM;

EID: 0037377081     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00735-6     Document Type: Review

References (82)

1. Bers D.M. Excitation-contraction coupling and cardiac contractile force. 2nd ed: 2001;Kluwer, Dordrecht. 427 pp.
2. Hasenfuss G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res. 37:1998;279-289.
3. Zipes D.P., Wellens H.J.J. Sudden cardiac death. Circulation. 98:1998;2334-2351.
4. Gray R.P., McIntyre H., Sheridan D.S., et al. Intracellular sodium and contractile function in hypertrophied human and guinea-pig myocardium. Pfluger's Arch. 442:2001;117-123.
5. i in pressure-overloaded guinea pig heart. Am J Hypertens. 8:1995;934-943.
6. Mészáros J., Khananshvili D., Hart G. Mechanisms underlying delayed afterdepolarizations in hypertrophied left ventricular myocytes of rats. Am J Physiol. 281:2001;H903-H914.
7. + concentration and altered Na/K pump activity in hypertrophied canine ventricular cells. Cardiovasc Res. 57:2003;1035-1043.
8. Baudet S., Noireaud J., Leoty C. Intracellular Na activity measurements in the control and hypertrophied heart of the ferret: an ion-sensitive micro-electrode study. Pfluger's Arch. 418:1991;313-318.
9. + concentration is elevated in heart failure, but Na/K pump function is unchanged. Circulation. 105:2002;2543-2548.
10. +-exchanger activity in heart failure causes disturbed calcium handling. Biophys J. 81:2002;598a.
11. i and contractility in nonfailing and failing human myocardium. Circulation. 106:2002;447-453.
12. 2+ homeostasis in rabbits with pacing-induced heart failure. Am J Physiol. 275:1998;H1441-H1448.
13. Sipido K.R., Volders P.G., Vos M.A., Verdonck F. Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: a new target for therapy? Cardiovasc Res. 53:2002;782-805.
14. Bers D.M., Barry W, Despa S. Intracellular Na regulation in cardiac myocytes. Cardiovasc Res 2003: in press.
15. +-ATPase activity in one-kidney, one-clip hypertensive rats. Am J Physiol. 245:1983;H244-H251.
16. 2+ transport activities in cardiac hypertrophy caused by pressure overload. Am J Physiol. 257:1989;H349-H356.
17. +-ATPase activity in congestive heart failure due to myocardial infarction. Am J Physiol. 62:1992;C664-C671.
18. Kim C.H., Fan T.H., Kelly P.F., et al. Isoform-specific regulation of myocardial Na,K-ATPase alpha-subunit in congestive heart failure. Role of norepinephrine. Circulation. 89:1994;313-320.
19. Panagia V., Singh J.N., Madhu B., et al. Sarcolemmal alterations during the development of genetically determined cardiomyopathy. Cardiovasc Res. 18:1984;567-572.
20. Calderon A., Bouvier M., Li K., et al. Dysfunction of the β- and α-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog. Circ Res. 69:1991;332-343.
21. Ellingsen O., Holthe M.R., Svindland A., et al. Na,K-pump concentration in hypertrophied human hearts. Eur Heart J. 15:1994;1184-1190.
22. Shamraj O.I., Grupp I.L., Grupp G., et al. Characterisation of Na/K-ATPase, its isoforms, and the inotropic response to ouabain in isolated failing human hearts. Cardiovasc Res. 27:1993;2229-2237.
23. 2+ exchanger protein levels in human heart failure. Circulation. 99:1999;2105-2112.
24. Norgaard A., Bagger J.P., Bjerregaard P., et al. Relation of left ventricular function and Na,K-pump concentration in suspected idiopathic dilated cardiomyopathy. Am J Cardiol. 61:1988;1312-1315.
25. +-ATPase subunit isoforms at mRNA and protein levels in rat myocardium. J Mol Cell Cardiol. 26:1994;591-600.
26. +-ATPase in spontaneously hypertensive rats: effect of antihypertensive therapy. Eur J Pharmacol. 327:1997;151-156.
27. +-ATPase and Na/Ca exchanger: hypertension, thyroid hormone, development. Am J Physiol. 269:1995;C675-C682.
28. +-ATPase isoforms in myocardium. Isoform change in deoxycorticosterone acetate-salt hypertension. Circ Res. 74:1994;669-678.
29. Charlemagne D., Orlowski J., Oliviero P., et al. Alterations of Na/K-ATPase subunit mRNA and protein levels in hypertrophied rat heart. J Biol Chem. 269:1994;1541-1547.
30. Semb S.O., Lunde P.K., Holt E., et al. Reduced myocardial Na/K pump capacity in congestive heart failure following myocardial infarction in rats. J Mol Cell Cardiol. 30:1998;1311-1328.
31. Allen D., Schmidt T.A., Marsh J.D., Kjeldsen K. Na,K-ATPase expression in normal and failing human left ventricle. Basic Res Cardiol. 87:(Suppl. 1):1992;87-94.
32. + exchange blockers. J Mol Cell Cardiol. 32:2000;1181-1192.
33. Undrovinas A.I., Maltsev V.A., Sabbah H.N. Repolarization abnormalities in cardiomyocytes of dogs with chronic heart failure: role of sustained inward current. Cell Mol Life Sci. 55:1999;494-505.
34. Maltsev V.A., Sabbah H.N., Higgins R.S., et al. Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes. Circulation. 98:1998;2545-2552.
35. + exchange hyperactivity and myocardial hypertrophy: Are they linked phenomenon? Cardiovasc Res. 44:1999;462-467.
36. + exchanger. Circ Res. 77:1995;1192-1200.
37. - anion-exchanger in the hypertrophied myocardium. Cardiovasc Res. 51:2001;71-79.
38. + pump activity in contracting rat muscle. J Physiol. 503:1997;571-581.
39. 2+ content in isolated failing and nonfailing human myocardium. Circ Res. 85:1999;38-46.
40. 2+ transients in failing human myocardium assessed with ryanodine. J Mol Cell Cardiol. 30:1998;1285-1294.
41. 2+ release from the sarcoplasmic reticulum in human ventricular myocytes from end-stage heart failure. Cardiovasc Res. 37:1998;478-488.
42. 2+ exchanger in end-stage human heart failure. Circ Res. 75:1994;443-453.
43. 2+ exchange in the infarcted heart. Implications for excitation-contraction coupling. Circ Res. 81:1997;1083-1093.
44. 2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation. 99:1999;641-648.
45. 2+ exchanger expression and function in an arrhythmogenic rabbit model of heart failure. Circ Res. 85:1999;1009-1019.
46. Pogwizd S.M., Schlotthauer K., Li L., Yuan W., Bers D.M. Arrhythmogenesis and contractile dysfunction in heart failure. Roles of sodium-calcium exchange, inward rectifier potassium current, and residual β-adrenergic responsiveness. Circ Res. 88:2001;1159-1167.
47. O'Rourke B., Kass D.A., Tomaselli G.F., et al. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure. I. Experimental studies. Circ Res. 84:1999;562-570.
48. 2 release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes. Potential link between contractile adaptation and arrhythmogenesis. Circulation. 102:2000;2137-2144.
49. 2+ cycling proteins underlie cardiac action potential prolongation in a pressure-overloaded guinea pig model with cardiac hypertrophy and failure. Circ Res. 86:2000;558-570.
50. 2+ exchanger in response to cardiac pressure overload. Am J Physiol. 265:1993;H1024-H1029.
51. + currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res. 73:1993;379-385.
52. Kaab S., Nuss H.B., Chiamvimonvat N., et al. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res. 78:1996;262-273.
53. Volders P.G.A., Sipido K.R., Vos M.A., et al. Downregulation of delayed rectifier K currents in dogs with chronic complete atrioventricular block and acquired torsade de pointes. Circulation. 100:1999;2455-2461.
54. Arai M., Alpert N.R., MacLennan D.H., Barton P., Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res. 72:1993;463-469.
55. 2+-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest. 85:1990;305-309.
56. 2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation. 90:1994;653-657.
57. Feldman A.M., Weinberg E.O., Ray P.E., Lorell B.H. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res. 73:1993;184-192.
58. Bers D.M., Pogwizd S.M., Schlotthauer K. Upregulated Na/Ca exchange is involved in both contractile dysfunction and arrhythmogenesis in heart failure. Basic Res Cardiol. 97:(Suppl 1):2002;36-42.
59. Hobai I.A., O'Rourke B. Decreased sarcoplasmic reticulum calcium content is responsible for defective excitation-contraction coupling in canine heart failure. Circulation. 103:2001;1577-1584.
60. Lindner M., Erdmann E., Beuckelmann D.J. Calcium content of the sarcoplasmic reticulum in isolated ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol. 30:1998;743-749.
61. 2+, fluxes and sarcoplasmic reticulum loading in pressure-overload hypertrophy. Am J Physiol. 272:1997;H2425-H2435.
62. Ito K., Yan X., Tajima M., et al. Contractile reserve and intracellular calcium regulation in mouse myocytes from normal and hypertrophied failing hearts. Circ Res. 87:2000;588-595.
63. Shorofsky S.R., Aggarwal R., Corretti M., Baffa J.M., et al. Cellular mechanisms of altered contractility in the hypertrophied heart: big hearts, big sparks. Circ Res. 84:1999;424-434.
64. Vos M.A., de Groot S.H.M., Verduyn S.C., et al. Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling. Circulation. 98:1998;1124-1135.
65. de Groot S.H.M., Schoenmakers M., Molenschot P., et al. Contractile adaptations preserving cardiac output predispose the hypertrophied canine heart to delayed afterdepolarization-dependent ventricular arrhythmias. Circulation. 102:2000;2145-2151.
66. Volders P.G.A., Sipido K.R., Vos M.A., et al. Cellular basis of biventricular hypertrophy and arrhythmogenesis in dogs with chronic complete atrioventricular block and acquired torsade de pointes. Circulation. 98:1998;1136-1147.
67. Pogwizd S.M. Nonreentrant mechanism underlying spontaneous ventricular arrhythmias in a model of nonischemic heart failure in rabbits. Circulation. 92:1995;1034-1048.
68. Weber C.R., Piacentino III V., Ginsburg K.S., et al. Na/Ca exchange current and submembrane [Ca] during the cardiac action potential. Circ Res. 90:2001;182-189.
69. 2+ channels in rabbit ventricular myocytes during action potential clamp: influence of temperature. Circ Res. 85:1999;e7-e16.
70. 2+ occurs during diastole and not systole in guinea-pig ventricular myocytes. Pfluger's Arch. 437:1999;731-736.
71. 2+ gain and systolic loss in isolated guinea-pig ventricular myocytes. J Physiol. 530:2001;487-495.
72. i. Circ Res. 78:1996;857-862.
73. Marx S.O., Reiken S., Hisamatsu Y., et al. phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. 101:2000;365-376.
74. Pogwizd S.M. Focal mechanism underlying ventricular tachycardia during prolonged ischemic cardiomyopathy. Circulation. 90:1994;1441-1458.
75. Vermeulen J.T., McGuire M.A., Opthof T., et al. Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. Cardiovasc Res. 28:1994;1547-1554.
76. Wit A.L., Rosen M.R. Afterdepolarizations and triggered activity: distinction from automaticity as an arrhythmogenic mechanism. Fozzard H.A., Haber E., Jennings R.B., Katz A.M., Morgan H.E. Heart and cardiovascular system: scientific foundations. 2nd ed: 1992;2113-2163 Raven Press, New York.
77. 2+ current. Circ Res. 64:1989;977-990.
78. Tomaselli G.F., Beuckelmann D.J., Calkins H.G., et al. Sudden cardiac death in heart failure. The role of abnormal repolarization. Circulation. 90:1994;2534-2539.
79. Fowler M.B., Laser J.A., Hopkins G.L., Minobe W., Bristow M.R. Assessment of β-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation. 74:1986;1290-1302.
80. Bristow M.R., Ginsburg R., Minobe W., et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. New Engl J Med. 307:1982;205-211.
81. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet. 353:1999;2001-2007.
82. Volders P.G.A., Kulcsar A., Vos M.A., Sipido K.P., et al. Similarities between early and delayed afterdepolarizations induced by isoproterenol in canine ventricular myocytes. Cardiovasc Res. 34:1997;348-359.